Jan. 8, 2025 – EDAP TMS SA, a supplier of robotic energy-based therapies, has announced that the first patient has been treated in a phase I/II PULS Trial sponsored by the Centre Léon Bérard, Lyon, France, evaluating proprietary High Intensity Focused Ultrasound (HIFU) technology for the treatment of pancreatic tumors.
Amid growing interest in unionization and recent strike activity among physicians, policies could be updated to better reflect the realities of modern health care and…
Covering the full spectrum of otolaryngology–head and neck surgery and facial plastic surgery, Handbook of Otolaryngology: Head and Neck Surgery, 3rd Edition, is packed with…
As researchers push for a type 1 diabetes cure, Sana Biotechnology has provided a nudge forward with new, if limited, clinical trial data.
At the J.P. Morgan Healthcare Conference, Boston Scientific forecast that pulsed field ablation will be used in more than 60% of atrial fibrillation procedures globally by…
Leading Communications and Technology Event Returns to Florida
Dr. Drew is an American radio and TV personality, physician, and addiction medicine specialist. He joins Zuby to talk about his background and the intersecti…
After buying old tapes, Max Ochester went to wipe one. But he listened to it first, just in case… and found a secret from music…
THURSDAY, Jan. 16, 2025 (HealthDay News) — Cancer mortality is continuing to decline, but the incidence of certain cancer types is increasing, especially among
We live in a modern world, and that world comes with some new, modern strains on our bodies. Our expert offers three tricks to relieve…
In this trial involving patients with hematologic cancers, the immune responses that were elicited were similar for adjuvanted-dose and standard-dose influenza vaccines.
